Cipla, leading drug maker, will be announcing its second quarter financial results on Thursday, Nov. 13, 2014.
Angel Broking expects the company to post sales of Rs 28.89 billion V/s Rs 24.63 billion, a growth of 17.3% yoy, to be driven by 16% yoy and 18.3% yoy domestic and exports respectively.
On the operating front, the gross margin is expected to come in at 61.3% V/s 61.6%. However, owing to a 32.4% and 14.8% yoy rise in staff cost and other expenditure respectively, the operating margins (OPM) is expected to come in at 19.3% V/s 20.9% in 2QFY2014, a yoy dip of 162bps. Thus, the Adj. net profit is expected to come in at Rs 3.83 billion, a growth of 7% yoy. We remain neutral on the stock, the broking firm said.